Amyloid l

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Amyloid L, abbreviated as "AL" (AL=amyloid light), belongs to a group of polymorphic fibre proteins which, in acquired amyloidosis, are deposited as insoluble, fibrillar aggregates in organs, vessels and nerves. Amyloidosis is caused by a disturbance in protein folding.

General informationThis section has been translated automatically.

Amyloid of the immunoglobulin light chain type (AL=amyloid light). Precursor proteins are monoclonal immunoglobulin light chains. According to the iso and idiotypes, AL proteins are chemically diverse. Two skin types are distinguished: Aκ and Aλ.

AL amyloid is present in a number of very different forms of amyloidosis, such as monoclonal gammopathy and malignant monoclonal B-cell proliferation (multiple myeloma, Bence-Jones plasmacytoma, Waldenström's disease, etc.).

Authors

Last updated on: 29.10.2020